¼¼°èÀÇ Ç×±Õ Á¤Çü¿Ü°ú ÀÓÇöõÆ® ½ÃÀå º¸°í¼­(2025³â)
Antibacterial Orthopedic Implant Global Market Report 2025
»óǰÄÚµå : 1764244
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,253,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,039,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,824,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ç×±Õ Á¤Çü¿Ü°ú ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 2029³âÀÇ ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR)Àº 9.5%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 62¾ï 3,000¸¸ ´Þ·¯·Î ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ¼ºÀåÀº ³»°¨¿°¼º ÀÓÇöõÆ®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Àΰø°üÀý ġȯ¼ú Áõ°¡, º´¿ø ³» °¨¿°¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, °¨¿° °ü¸® °­È­¸¦ À§ÇÑ Á¤ºÎÀÇ ³ë·Â, ÀºÀ̿ ±â¹Ý ÀÓÇöõÆ® ÀÌ¿ë È®´ë µî¿¡ ±âÀÎÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ±â°£¿¡ ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Ç×±Õ ÄÚÆÃÀÇ ±â¼úÀû ¹ßÀü, ÀÓÇöõÆ® Àç·á °úÇÐÀÇ Áøº¸, ÀÓÇöõÆ®¿¡ ³ª³ë±â¼ú µµÀÔ, »ýºÐÇØ¼º Ç×±Õ ÄÚÆÃÀ¸·ÎÀÇ ÀÌÇà, ȯÀÚ Àü¿ë 3D ÇÁ¸°ÆÃ ÀÓÇöõÆ® °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·üÀÇ »ó½ÂÀº ÇâÈÄ ¼ö³â°£ Ç×±Õ Á¤Çü¿Ü°ú ÀÓÇöõÆ® ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á¤Çü¿Ü°ú Áúȯ¿¡´Â »À, °üÀý, ±ÙÀ°, ÈûÁÙ, ÀÎ´ë µîÀÇ ±Ù°ñ°Ý°è¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â º´¼¼°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ Áõ°¡ÀÇ ÁÖ¿ä ¿øÀÎÀº °í·ÉÈ­À̸ç, °í·ÉÀÚ´Â ½Ã°£ÀÇ °æ°ú¿¡ µû¸¥ ±Ù°ñ°Ý°èÀÇ ÀÚ¿¬ÀûÀÎ ¸¶¸ð³ª ¼Õ»ó¿¡ ±âÀÎÇÏ´Â º¯Çü¼º °üÀýÁõ, °ñ´Ù°øÁõ, °üÀý º¯¼º µîÀÇ Áõ»ó¿¡ °É¸®±â ½¬¿öÁý´Ï´Ù. Ç×±Õ Á¤Çü¿Ü°ú ÀÓÇöõÆ®´Â ¼ö¼ú ÈÄ °¨¿° À§ÇèÀ» ³·Ãß°í Á¶±â ȸº¹À» Áö¿øÇϸç ÀÓÇöõÆ® ¼ö¼úÀÇ Àå±âÀûÀÎ ¼º°øÀ» ³ôÀÓÀ¸·Î½á ÀÌ·¯ÇÑ Àå¾Ö¸¦ °ü¸®ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 3¿ù ¿µ±¹ Á¤ºÎºÎ¹® Office for Health Improvement and Disparities´Â 2022³â 16¼¼ ÀÌ»ó 17.6%°¡ °üÀý¿°À̳ª µî°ú °üÀýÀÇ Áö¼ÓÀûÀÎ ¹®Á¦ µî Àå±âÀûÀÎ ±Ù°ñ°Ý°è(MSK) ÁúȯÀ» ÀÚÁø ½Å°íÇß´Ù°í º¸°íÇß°í, ÀÌ´Â 2021³â 17.0%¿¡¼­ Áõ°¡Çß½À´Ï´Ù. ÀÌó·³ Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ Ç×±Õ Á¤Çü¿Ü°ú ÀÓÇöõÆ® ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Ç×±Õ Á¤Çü¿Ü°ú ÀÓÇöõÆ® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­Çϰí ȯÀÚÀÇ ¿¹Èĸ¦ Çâ»ó½Ã۱â À§ÇØ Ç×±Õ ÄÚÆÃ ÀÓÇöõÆ®¿Í °°Àº Çõ½ÅÀûÀÎ Á¦Ç° °³¹ßÀ» ¼±È£ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀÓÇöõÆ®´Â ¼¼±ÕÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÏ´Â Ç×±Õ¼º ¹°Áú·Î ÄÚÆÃµÇ¾î Àֱ⠶§¹®¿¡ °¨¿° °¡´É¼ºÀ» ³·Ãß°í ´õ ³ªÀº Ä¡À¯¸¦ Áö¿øÇÏ¸ç ¿Ü°ú ¼ö¼úÀÇ Àå±âÀûÀÎ ¼º°øÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 4¿ù ¹Ì±¹ ÀÇ·á±â±â ¾÷üÀÎ ¿ÂÄÚ½º ¼­ÁöÄÃÀº Ç×±Õ¼º ÄÚÆÃÀ» ÇÑ ÀÓÇöõÆ®¿¡ ´ëÇØ ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. ÀÌ ÀÌÁ¤Ç¥¸¦ ÅëÇØ ȸ»ç´Â Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ®, ƯÈ÷ Á¾¾ç ¼ö¼úÀ̳ª Àç¼ö¼ú°ú °°Àº À§ÇèÇÑ ¼ö¼ú¿¡ À־ ¼¼±Õ ¿À¿°°ú ½Î¿ì´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ ±â¼úÀ» Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ ÀÚü ÄÚÆÃÀº ÀκñÆ®·Î °Ë»ç¿¡¼­ 99.999%ÀÇ »ì±Õ·üÀ» ´Þ¼ºÇÏ¿© ÀÓÇöõÆ®ÀÇ ºÒ·®, °¨¿°, Àý´Ü µîÀÇ ½É°¢ÇÑ ÇÕº´ÁõÀ» ¿¹¹æÇÏ´Â À¯¸ÁÇÑ ¼Ö·ç¼ÇÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ ¹× Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï ¹× °ü¼¼, Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼® ¹× Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº° ¹× ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ ¹× ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å· ¹× ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹® ¹× Àü·«

Á¦36Àå ºÎ·Ï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

An antibacterial orthopedic implant is a type of medical device utilized in orthopedic surgeries that incorporates antibacterial features to minimize the risk of post-surgical infections. Its mechanism of action usually involves the controlled release of antimicrobial agents from the surface of the implant. These agents either damage bacterial cell walls or inhibit bacterial enzyme functions, thereby preventing bacterial colonization. This approach aids in maintaining a sterile environment around the implant site, supporting quicker recovery and lowering the chances of complications for patients.

The primary categories of antibacterial orthopedic implants include antibacterial bone cement, bone screws, bone plates, joint implants, and spinal implants. Antibacterial bone cement, used to affix implants to bone, contains antimicrobial substances to guard against infection during the healing phase. Frequently used antibacterial agents are silver, chlorhexidine, triclosan, iodine, and vancomycin. These implants are manufactured from a variety of materials, including metals, polymers, ceramics, and composites. They are commonly applied in procedures such as joint replacements, trauma surgeries, spinal operations, and other orthopedic interventions. The main end users of these implants include hospitals, ambulatory surgical centers, clinics, academic and research institutions, and the defense and military sectors.

The antibacterial orthopedic implant market research report is one of a series of new reports from The Business Research Company that provides antibacterial orthopedic implant market statistics, including antibacterial orthopedic implant industry global market size, regional shares, competitors with the antibacterial orthopedic implant market share, antibacterial orthopedic implant market segments, market trends, and opportunities, and any further data you may need to thrive in the antibacterial orthopedic implant industry. This antibacterial orthopedic implant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antibacterial orthopedic implant market size has grown strongly in recent years. It will grow from $3.95 billion in 2024 to $4.33 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period can be credited to several factors, including the rising number of orthopedic injuries, an expanding elderly population, an increased occurrence of post-surgical infections, greater use of trauma fixation techniques, and the growing adoption of minimally invasive orthopedic procedures.

The antibacterial orthopedic implant market size is expected to see strong growth in the next few years. It will grow to $6.23 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The anticipated growth in the forecast period can be attributed to the rising demand for infection-resistant implants, an increasing number of joint replacement surgeries, heightened awareness of hospital-acquired infections, government efforts to enhance infection control, and the growing utilization of silver-ion-based implants. Key trends expected during this period include technological advancements in antibacterial coatings, progress in implant material science, the incorporation of nanotechnology into implants, a transition toward biodegradable antibacterial coatings, and the development of patient-specific 3D-printed implants.

The rising prevalence of orthopedic disorders is anticipated to drive the growth of the antibacterial orthopedic implant market in the coming years. Orthopedic disorders encompass medical conditions that affect the musculoskeletal system, including bones, joints, muscles, tendons, and ligaments. This increase is largely attributed to the aging population, as older individuals are more susceptible to conditions like osteoarthritis, osteoporosis, and joint degeneration resulting from the natural wear and tear of the musculoskeletal system over time. Antibacterial orthopedic implants play a crucial role in managing these disorders by reducing the risk of post-surgical infections, supporting quicker recovery, and enhancing the long-term success of implant procedures. For example, in March 2023, the Office for Health Improvement and Disparities, a UK government department, reported that in 2022, 17.6% of people aged 16 and above self-reported a long-term musculoskeletal (MSK) condition, such as arthritis or ongoing issues with the back or joints-an increase from 17.0% in 2021. Thus, the growing prevalence of orthopedic conditions is contributing to the expansion of the antibacterial orthopedic implant market.

Leading companies in the antibacterial orthopedic implant market are prioritizing the development of innovative products, such as antibacterial coated implants, to minimize infection risks and enhance patient outcomes. These implants are coated with antibacterial substances that inhibit bacterial growth, thereby reducing the likelihood of infection, supporting better healing, and improving the long-term success of surgical procedures. For example, in April 2024, Onkos Surgical Inc., a U.S.-based medical equipment manufacturer, received approval from the U.S. Food & Drug Administration (FDA) for its antibacterial coated implants. This milestone enables the company to offer a technology aimed at combating bacterial contamination in orthopedic implants, particularly in high-risk procedures like tumor and revision surgeries. The proprietary coating has demonstrated bactericidal properties, achieving a 99.999% kill rate in in-vitro testing, presenting a promising solution to prevent serious complications such as implant failure, infection, and amputation.

In May 2023, Zimmer Biomet Holdings, Inc., a U.S.-based medical device company, acquired OSSIS for an undisclosed amount. This acquisition is intended to enhance Zimmer Biomet's hip reconstruction product portfolio by incorporating OSSIS's expertise in personalized 3D-printed implants and complex hip replacement solutions, thereby driving innovation and improving patient outcomes. OSSIS Corporation, based in New Zealand, specializes in the development of customized 3D-printed antibacterial orthopedic implants.

Major players in the antibacterial orthopedic implant market are Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, DePuy Synthes Inc., Exactech Inc., MicroPort Orthopedics Inc., Tegra Medical LLC, Implantcast GmbH, aap Implantate AG, Accentus Medical Ltd., Onkos Surgical Inc., BONESUPPORT AB, Heraeus Medical GmbH, Promimic AB, Silver Bullet Therapeutics Inc., TEKNIMED S.A.S., BioMedtrix LLC, BioGate AG, Tecres S.p.A., Kyocera Medical Technologies Inc.

North America was the largest region in the antibacterial orthopedic implant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antibacterial orthopedic implant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antibacterial orthopedic implant market consists of sales of shoulder prosthesis, antibacterial prosthetic implants, antibacterial trauma implants, antibacterial bone grafts, antibacterial biodegradable implants, and antibacterial arthroplasty implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antibacterial Orthopedic Implant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antibacterial orthopedic implant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for antibacterial orthopedic implant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibacterial orthopedic implant market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Antibacterial Orthopedic Implant Market Characteristics

3. Antibacterial Orthopedic Implant Market Trends And Strategies

4. Antibacterial Orthopedic Implant Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Antibacterial Orthopedic Implant Growth Analysis And Strategic Analysis Framework

6. Antibacterial Orthopedic Implant Market Segmentation

7. Antibacterial Orthopedic Implant Market Regional And Country Analysis

8. Asia-Pacific Antibacterial Orthopedic Implant Market

9. China Antibacterial Orthopedic Implant Market

10. India Antibacterial Orthopedic Implant Market

11. Japan Antibacterial Orthopedic Implant Market

12. Australia Antibacterial Orthopedic Implant Market

13. Indonesia Antibacterial Orthopedic Implant Market

14. South Korea Antibacterial Orthopedic Implant Market

15. Western Europe Antibacterial Orthopedic Implant Market

16. UK Antibacterial Orthopedic Implant Market

17. Germany Antibacterial Orthopedic Implant Market

18. France Antibacterial Orthopedic Implant Market

19. Italy Antibacterial Orthopedic Implant Market

20. Spain Antibacterial Orthopedic Implant Market

21. Eastern Europe Antibacterial Orthopedic Implant Market

22. Russia Antibacterial Orthopedic Implant Market

23. North America Antibacterial Orthopedic Implant Market

24. USA Antibacterial Orthopedic Implant Market

25. Canada Antibacterial Orthopedic Implant Market

26. South America Antibacterial Orthopedic Implant Market

27. Brazil Antibacterial Orthopedic Implant Market

28. Middle East Antibacterial Orthopedic Implant Market

29. Africa Antibacterial Orthopedic Implant Market

30. Antibacterial Orthopedic Implant Market Competitive Landscape And Company Profiles

31. Antibacterial Orthopedic Implant Market Other Major And Innovative Companies

32. Global Antibacterial Orthopedic Implant Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antibacterial Orthopedic Implant Market

34. Recent Developments In The Antibacterial Orthopedic Implant Market

35. Antibacterial Orthopedic Implant Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â